Live Quote · NASDAQVLNSHealthcare· Drug Manufacturers - Specialty & Generic

The Valens Company Inc.

$0.76 0.00%(+$0.00)
TickerSpark Score
61/100
Mixed
100
Valuation
40
Profitability
72
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VLNS research report →

52-Week Range7% of range
Low
$0.58
Current
$0.76
High
$3.00
Company Overviewwww.thevalenscompany.com

About the company

The Valens Company Inc. is a Canadian-headquartered enterprise with international reach, focused on the development, manufacturing, and sale of cannabinoid-based products. Its product portfolio encompasses dried cannabis and hemp biomass, alongside a wide array of consumer goods such as tinctures, two-piece caps, soft gels, oral sprays, vape pens, beverages, diverse concentrates, topicals, edibles, and natural health products.

CEO
Jeffrey Fallows CFA
IPO
2009
Employees
445
HQ
Toronto, ON, CA

Price Chart

-66.21% · this period
$2.82$1.71$0.61Jan 13Jul 18Jan 13
Valuation
Market Cap
$61.46M
P/E
-0.88
P/S
0.00
P/B
0.17
EV/EBITDA
0.02
Div Yield
0.00%
Profitability
Gross Margin
22.05%
Op Margin
-69.06%
Net Margin
-62.72%
ROE
-25.35%
ROIC
-16.24%
Performance & Tape
52W High
$3.00
52W Low
$0.58
50D MA
$0.78
200D MA
$0.79
Beta
0.00
Avg Volume
120.95K

Get TickerSpark's AI analysis on VLNS

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · VLNS

Our VLNS coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on VLNS yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate VLNS report →
Internal Compare

Similar companies

Peers in the same neighborhood.